Search research articles
Contact Us
Filters
Showing results (41-50 of 93) with videos related to
Page
of 10
Sort By:
Neurology
|
May 6, 2018
<i>FGFR1</i> actionable mutations, molecular specificities, and outcome of adult midline gliomas
Alberto Picca, Giulia Berzero, Franck Bielle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2024
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas
Alberto Picca, Mehdi Touat, Lisa Belin, et al.
Diagnostics (Basel, Switzerland)
|
November 27, 2021
A Predictive Clinical-Radiomics Nomogram for Survival Prediction of Glioblastoma Using MRI
Samy Ammari, Raoul Sallé de Chou, Corinne Balleyguier, et al.
Neuropathology and Applied Neurobiology
|
September 30, 2025
A Specific Methylation Class Identifies BAP1-Deficient Meningiomas, Including Meningeal Tumours With Poorly Differentiated Nonrhabdoid Histology
Philippe Drabent, Mehdi Touat, Patrick R Benusiglio, et al.
Journal of Neurosurgery
|
February 28, 2025
Safety and therapeutic impact of stereotactic biopsy in very elderly patients with brain tumors
Louise Deboeuf, Maximilien Riche, Henri Malaizé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2026
18F-DOPA-PET and advanced MRI improve treatment response assessment in IDH1/2-mutant gliomas treated with IDH inhibitors
Diego Prost, Lucia Nichelli, Laura Rozenblum, et al.
The Oncologist
|
July 27, 2019
Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations
William Boisseau, Philipp Euskirchen, Karima Mokhtari, et al.
Journal of Neurosurgery
|
September 10, 2021
Severity, timeline, and management of complications after stereotactic brain biopsy
Maximilien Riche, Pauline Marijon, Aymeric Amelot, et al.
Neuropathology and Applied Neurobiology
|
July 28, 2023
A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant
Suzanne Tran, Alice Thomas, Ilyes Aliouat, et al.
Neuropathology and Applied Neurobiology
|
September 23, 2023
Hippocampal and neocortical BRAF mutant non-expansive lesions in focal epilepsies
Julie Lerond, Bertrand Mathon, Mélina Scopin, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 93) with videos related to
Sort By:
Page
of 10
Neurology
|
May 6, 2018
<i>FGFR1</i> actionable mutations, molecular specificities, and outcome of adult midline gliomas
Alberto Picca, Giulia Berzero, Franck Bielle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2024
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas
Alberto Picca, Mehdi Touat, Lisa Belin, et al.
Diagnostics (Basel, Switzerland)
|
November 27, 2021
A Predictive Clinical-Radiomics Nomogram for Survival Prediction of Glioblastoma Using MRI
Samy Ammari, Raoul Sallé de Chou, Corinne Balleyguier, et al.
Neuropathology and Applied Neurobiology
|
September 30, 2025
A Specific Methylation Class Identifies BAP1-Deficient Meningiomas, Including Meningeal Tumours With Poorly Differentiated Nonrhabdoid Histology
Philippe Drabent, Mehdi Touat, Patrick R Benusiglio, et al.
Journal of Neurosurgery
|
February 28, 2025
Safety and therapeutic impact of stereotactic biopsy in very elderly patients with brain tumors
Louise Deboeuf, Maximilien Riche, Henri Malaizé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2026
18F-DOPA-PET and advanced MRI improve treatment response assessment in IDH1/2-mutant gliomas treated with IDH inhibitors
Diego Prost, Lucia Nichelli, Laura Rozenblum, et al.
The Oncologist
|
July 27, 2019
Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations
William Boisseau, Philipp Euskirchen, Karima Mokhtari, et al.
Journal of Neurosurgery
|
September 10, 2021
Severity, timeline, and management of complications after stereotactic brain biopsy
Maximilien Riche, Pauline Marijon, Aymeric Amelot, et al.
Neuropathology and Applied Neurobiology
|
July 28, 2023
A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant
Suzanne Tran, Alice Thomas, Ilyes Aliouat, et al.
Neuropathology and Applied Neurobiology
|
September 23, 2023
Hippocampal and neocortical BRAF mutant non-expansive lesions in focal epilepsies
Julie Lerond, Bertrand Mathon, Mélina Scopin, et al.
Page
of 10